Title Effects of enantiomers of $M_{3}$ antagonists on muscarinic receptors in rabbit trachea Author Loenders, B. Rampart, M. Herman, A.G. Faculty/Department Faculty of Pharmaceutical, Biomedical and Veterinary Sciences. Pharmacy Faculty of Medicine and Health Sciences Publication type article Publication 1994 Gent , 1994 Subject Pharmacology. Therapy Source (journal) Archives internationales de pharmacodynamie et de thérapie. - Gent Volume/pages 328(1994) :2 , p. 225-234 ISSN 0003-9780 ISI A1994QC61500009 Carrier E Target language English (eng) Affiliation University of Antwerp Abstract The effects of the enantiomers of structurally related chiral M(3) antagonists (trihexyphenidyl, p-fluorohexahydrodifenidol, hexahydrodifenidol and p-fluorohexbutinol) were studied at the presynaptic M(2) and postsynaptic M(3) receptor level in the rabbit trachea. All isomers were M(3)- over M(2)-selective as they did not increase the release of acetylcholine (an M(2) effect) at concentrations that significantly inhibited smooth muscle contraction (an M(3) effect). At the smooth muscle receptor, the R-enantiomers were consistently more potent than the S-enantiomers. The potency ratios (IC50(S)/IC50(R)) varied from 6 for p-fluorohexbutinol to 288 for trihexyphenidyl, and increased with higher eutomer potencies, in accordance to Pfeiffer's rule. Furthermore, we found that the potency of the racemic mixture of hexahydrodifenidol was significantly lower than that of the eutomer R-hexahydrodifenidol. To exclude that this difference was due to the lower concentration of the more active isomer, present in a racemic mixture, we calculated the potencies (-log IC50 values) of mixtures of the isomers of hexahydrodifenidol with varying amounts of S-hexahydrodifenidol and a constant amount of R-hexahydrodifenidol. We found that the presence of the distomer altered the potency of the eutomer in a dose-related manner. In conclusion, we have shown that the muscarinic smooth muscle receptor can be blocked differentially by the isomers of muscarinic antagonists and that the presence of the less active compound alters the potency of the most active isomer. We, therefore, suggest that, in bronchodilating therapy, the use of the pure eutomer might have advantages. E-info http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994QC61500009&DestLinkType=RelatedRecords&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994QC61500009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848 http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994QC61500009&DestLinkType=CitingArticles&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848 Handle